YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams
Natura:	Artigo
Lingua:	inglese
Pubblicazione:	2019
Accesso online:	https://doi.org/10.3390/ijms20030638 https://www.mdpi.com/1422-0067/20/3/638/pdf?version=1549024629
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
di: Van Haele, Matthias, et al.
Pubblicazione: (2019)

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
di: Iván M. Moya, et al.
Pubblicazione: (2019)

High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
di: Olivier Govaere, et al.
Pubblicazione: (2018)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
di: Olivier Govaere, et al.
Pubblicazione: (2017)

Human Liver Regeneration: An Etiology Dependent Process
di: Van Haele, Matthias, et al.
Pubblicazione: (2019)

Human Liver Regeneration: An Etiology Dependent Process
di: Matthias Van Haele, et al.
Pubblicazione: (2019)

YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis
di: Xiaohong Wang, et al.
Pubblicazione: (2017)

Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
di: Elisabeth Verboven, et al.
Pubblicazione: (2020)

Cell Junctions in Hippo Signaling
di: Karaman, Ruchan, et al.
Pubblicazione: (2018)

Cell Junctions in Hippo Signaling
di: Ruçhan Karaman, et al.
Pubblicazione: (2017)

Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected
di: Gilbo, Nicholas, et al.
Pubblicazione: (2019)

YAP/TAZ at the roots of cancer
di: Zanconato, Francesca, et al.
Pubblicazione: (2016)

YAP/TAZ at the Roots of Cancer
di: Francesca Zanconato, et al.
Pubblicazione: (2016)

Roles of YAP/TAZ in ferroptosis
di: Suchitra Magesh, et al.
Pubblicazione: (2022)

Septuagenarian and Octogenarian Donors Provide Excellent Liver Grafts for Transplantation
di: Tom Darius, et al.
Pubblicazione: (2012)

The emerging roles of YAP and TAZ in cancer
di: Moroishi, Toshiro, et al.
Pubblicazione: (2015)

DNA binding partners of YAP/TAZ
di: Kim, Min-Kyu, et al.
Pubblicazione: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
di: Park, Jeong Ae, et al.
Pubblicazione: (2018)

YAP/TAZ as therapeutic targets in cancer
di: Zanconato, Francesca, et al.
Pubblicazione: (2016)

Mechanobiology of YAP and TAZ in physiology and disease
di: Panciera, Tito, et al.
Pubblicazione: (2017)

The emerging role of YAP/TAZ in mechanotransduction
di: Mohri, Zahra, et al.
Pubblicazione: (2017)

YAP and TAZ regulate cell volume
di: Perez-Gonzalez, Nicolas A., et al.
Pubblicazione: (2019)

Mechanisms of YAP/TAZ transcriptional control
di: Battilana, Giusy, et al.
Pubblicazione: (2021)

YAP/TAZ in Bone and Cartilage Biology
di: Zarka, Mylène, et al.
Pubblicazione: (2022)

YAP/TAZ as therapeutic targets in cancer
di: Francesca Zanconato, et al.
Pubblicazione: (2016)

Interplay between YAP/TAZ and Metabolism
di: Ja Hyun Koo, et al.
Pubblicazione: (2018)

Mechanobiology of YAP and TAZ in physiology and disease
di: Tito Panciera, et al.
Pubblicazione: (2017)

The emerging roles of YAP and TAZ in cancer
di: Toshiro Moroishi, et al.
Pubblicazione: (2015)

DNA binding partners of YAP/TAZ
di: Min‐Kyu Kim, et al.
Pubblicazione: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
di: Jeong Ae Park, et al.
Pubblicazione: (2018)

YAP/TAZ in Bone and Cartilage Biology
di: Mylène Zarka, et al.
Pubblicazione: (2022)

Mechanisms of YAP/TAZ transcriptional control
di: Giusy Battilana, et al.
Pubblicazione: (2021)

Nuclear Import and Export of YAP and TAZ
di: Michael Kofler, et al.
Pubblicazione: (2023)

YAP and TAZ regulate cell volume
di: Nicolas A. Perez-Gonzalez, et al.
Pubblicazione: (2019)

The emerging role of YAP/TAZ in mechanotransduction
di: Zahra Mohri, et al.
Pubblicazione: (2017)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
di: Govaere, O, et al.
Pubblicazione: (2017)

RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
di: Ceulemans, An, et al.
Pubblicazione: (2017)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
di: Merritt, Nicole, et al.
Pubblicazione: (2021)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
di: Nicole Merritt, et al.
Pubblicazione: (2021)

The Impact of Liver Transplantation after Surgical Treatment of Hepatocellular Carcinoma
di: Topal, Halit, et al.
Pubblicazione: (2014)